Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

612 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.
Waldmann TA. Waldmann TA. Nat Rev Immunol. 2006 Aug;6(8):595-601. doi: 10.1038/nri1901. Nat Rev Immunol. 2006. PMID: 16868550 Review.
Prolongation of graft survival in primate allograft transplantation by yttrium-90-labeled anti-Tac in conjunction with granulocyte colony-stimulating factor.
Parenteau GL, Dirbas FM, Garmestani K, Brechbiel MW, Bukowski MA, Goldman CK, Clark R, Gansow OA, Waldmann TA. Parenteau GL, et al. Among authors: waldmann ta. Transplantation. 1992 Dec;54(6):963-8. doi: 10.1097/00007890-199212000-00004. Transplantation. 1992. PMID: 1281566
Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptor.
Kreitman RJ, Schneider WP, Queen C, Tsudo M, Fitzgerald DJ, Waldmann TA, Pastan I. Kreitman RJ, et al. Among authors: waldmann ta. J Immunol. 1992 Oct 15;149(8):2810-5. J Immunol. 1992. PMID: 1401913
The interleukin-2 receptor: a target for immunotherapy.
Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Adv Exp Med Biol. 1992;323:57-66. doi: 10.1007/978-1-4615-3396-2_8. Adv Exp Med Biol. 1992. PMID: 1485565 Review. No abstract available.
The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit.
Grant AJ, Roessler E, Ju G, Tsudo M, Sugamura K, Waldmann TA. Grant AJ, et al. Among authors: waldmann ta. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2165-9. doi: 10.1073/pnas.89.6.2165. Proc Natl Acad Sci U S A. 1992. PMID: 1549576 Free PMC article.
Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection.
Waldmann TA. Waldmann TA. Annu Rev Immunol. 1992;10:675-704. doi: 10.1146/annurev.iy.10.040192.003331. Annu Rev Immunol. 1992. PMID: 1590999 Review.
The multichain interleukin-2 receptor: a target for immunotherapy.
Waldmann TA, Pastan IH, Gansow OA, Junghans RP. Waldmann TA, et al. Ann Intern Med. 1992 Jan 15;116(2):148-60. doi: 10.7326/0003-4819-116-2-148. Ann Intern Med. 1992. PMID: 1727619 Review.
Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL, Greenberg SJ, Burton JD, Danielpour D, Kim SJ, Blattner WA, Manns A, Waldmann TA. Tendler CL, et al. Among authors: waldmann ta. J Cell Biochem. 1991 Aug;46(4):302-11. doi: 10.1002/jcb.240460405. J Cell Biochem. 1991. PMID: 1757474
Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiency.
Waldmann TA. Waldmann TA. Clin Immunol Immunopathol. 1991 Nov;61(2 Pt 2):S37-46. doi: 10.1016/s0090-1229(05)80036-4. Clin Immunol Immunopathol. 1991. PMID: 1934612 Review.
IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes.
Lorberboum-Galski H, Garsia RJ, Gately M, Brown PS, Clark RE, Waldmann TA, Chaudhary VK, FitzGerald DJ, Pastan I. Lorberboum-Galski H, et al. Among authors: waldmann ta. J Biol Chem. 1990 Sep 25;265(27):16311-7. J Biol Chem. 1990. PMID: 1975810
612 results
Jump to page